- Rating
- 1
- Confidence
- 2
- Informativeness
- 1
- Presentation
- 1
- Soundness
- 2
Read review
Paper summary
The authors formulate cross-modal disease timing across unpaired cohorts as a partial identification problem and introduce ClockBridge, a set-valued alignment framework that reports temporal orderings only when invariant across stage-compatible alignments (SES) and abstains otherwise. On ADNI, PD, and unpaired molecular–imaging cohorts, ClockBridge lowers false-order risk and cross-cohort claim contradictions compared to point estimators and forced single-timeline baselines.
Critical strengths
- Motivation: Rightly challenges the assumption of a shared cross-cohort disease timeline.
- Uncertainty Handling: Abstaining under ambiguous stage evidence is methodologically sound.
Critical weaknesses
-
Unclear presentation and logical flow. The manuscript does not clearly connect the biomedical question, modeling assumptions, method, and evaluation. Several concepts are introduced without sufficiently clear definitions or explanations. For example, the manuscript does not clearly specify what constitutes a "witness," how "bidirectional capacity" is calculated, or what criteria distinguish "not-evaluable" from "unresolved" outcomes. These make it difficult to follow the method and understand how the available evidence supports the conclusions.
-
Insufficient justification for temporal identification. The paper does not adequately explain why its alignment loss captures meaningful temporal correspondence between modalities, or why the SES should contain the true correspondence. Thus, alignment consistency does not guarantee biological correctness.
-
Insufficient and unclear validation. Under the translation model (Sec. 3.2, Eq. 1), the common shift cancels from the predicted pairwise differences used for ordering (Appendix A.3). It is therefore unclear how the ordering metrics in Table 1 assess synchronization accuracy. Appendix A.3 also introduces "true local coordinates" without clearly specifying how they are obtained, while Sec. 4.1 describes PD pairing through "subject co-enrollment" without establishing temporal correspondence between scans. The external experiments assess cohort-replacement stability rather than temporal correctness (Sec. 4.4). Finally, Table A6 reports top-20/25/30 decided claims per replacement block, although Table A5 lists only 19 decided ClockBridge claims for molecular replacement and 28 for imaging replacement. This discrepancy requires clarification.
-
Unclear source of improvement. The experiments do not show whether the gains come from the SES itself or from confidence scoring and abstaining on difficult cases. Comparisons with uncertainty-aware alignment methods are also insufficient. In the acquisition study, it remains unclear what new data are collected and how they update the timing conclusions.
Questions for authors
- How does Equation (3) compare distinct feature spaces without absorbing true biological latency?
- What estimand and assumptions define the identified set? When does the empirical -sublevel set contain the true synchronization, and how is calibrated?
- How can pairwise ordering assess a common translation when the offset cancels?
- How are 20, 25, or 30 decided claims selected per block when Table A5 reports only 19 or 28?
- How are "true local coordinates" obtained? What temporal reference does PD co-enrollment provide when scan dates differ?
- Do improvements persist with comparable uncertainty estimation and abstention for baselines, evaluated on a common test population?
- What does each acquisition action observe, and how are its outcomes, costs, and evidence updates defined?